Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Breen
A Phase I/Ii Trial of BNC105P With Everolimus in Metastatic Renal Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
P1.16-01 Prognostic Variables Associated With Improved Outcomes in Stage III NSCLC Patients Treated With Consolidation Pembrolizumab
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma
Urology
Urology
The Effect of Everolimus and Low-Dose Cyclophosphamide on Immune Cell Subsets in Patients With Metastatic Renal Cell Carcinoma: Results From a Phase I Clinical Trial
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Recombinant Human Interleukin 6 in Metastatic Renal Cell Cancer: A Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
Oncologist
Cancer Research
Medicine
Oncology
Everolimus in Metastatic Renal Cell Carcinoma : Preliminary Experience From Chang Gung Memorial Hospital
Biomedical Journal
Medicine
A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients With Metastatic Renal Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Phase II Trial of Fenretinide in Advanced Renal Carcinoma
Investigational New Drugs
Oncology
Pharmacology
Perioperative Immunomodulation With Interleukin-2 in Patients With Renal Cell Carcinoma: Results of a Controlled Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
